2024-10-20 07:39:28
Bridge Biotherapeutics Announces First Patient Dosed in its Phase 2a Clinical Trial of BBT-877, a Potent Autotaxin Inhibitor for the Treatment of Idiopathic Pulmonary Fibrosis
Corporate/ 2023-07-24
Bridge Biotherapeutics Announces First P...

SEONGNAM,South Korea and CAMBRIDGE,Mass.,April 13,2023-- Bridge Biotherapeutics (KQ288330),a clinical-stage biotech company based in South K...

Smart Physiotherapy Systems: One-Stop Solution for Pain Patients
Health/ 2023-07-22
Smart Physiotherapy Systems: One-Stop So...

WUHAN,China,April 13,2023--Rhein Laser Technologies Ltd.,a leading manufacturer of innovative medical lasers for urologic,aesthetic and phys...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release